Neutral dimeric copper-sparfloxacin conjugate having butterfly motif with antiproliferative effects against hormone independent BT20 breast cancer cell line

Inorganic Chemistry Communications

Volumn 10, Issue 4, 2007, Pages 459-462

  Shingnapurkar, Dipti ^a   Butcher, Ray ^b   Afrasiabi, Zahra ^c   Sinn, Ekkhard ^c   Ahmed, Fakhara ^d   Sarkar, Fazlul ^d   Padhye, Subhash ^a  

^a UNIVERSITY OF PUNE   (India)

^b HOWARD UNIVERSITY   (United States)

^c MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Copper dimer; Phenanthroline adduct; Sparfloxacin; X ray crystal structure

Indexed keywords

EID: 33847295106     PISSN: 13877003     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inoche.2006.12.016     Document Type: Article

References (29)

1. De Souza M., Vasconcelosa T.R., Almeidab M.V., and Cardosob S.H. Curr. Med. Chem. 13 (2006) 455
2. Drlica K., and Zhao X. Microb. Mol. Biol. Rev. 61 (1997) 377
3. Truffot-Pernot C.L., Grosset M., and Ji B. Antimicrob. Agents Chemother. 37 (1993) 407
4. Sissi C., and Palumbo M. Curr. Med. Chem. Anticancer Agents 3 (2003) 439
5. Ebisuno S., Inagaki T., Kohjimoto Y., and Ohkawa T. Cancer 80 (1997) 2263
6. Seay T., Peretsamn S., and Dixon P. J. Urology 155 (1996) 757
7. Arahana O., Wood Jr. D., and Sarkar F. Clin. Cancer Res. 6 (2000) 891
8. Mukherjee P., Mandal E., and Das S. Int. J. Hum. Genet. 5 1 (2005) 57
9. Yamakuchi M., Nakata M., Kawahara K., Kitajima I., and Maruyama I. Cancer Lett. 119 (1997) 213
10. Turel I. Coordin. Chem. Rev. 232 (2002) 27
11. Drevenšek P., Zupančič T., Pihlar B., Jerala R., Kolitsch U., Plaper A., and Turel I. J. Inorg. Biochem. 99 (2005) 432
12. Saha D.K., Padhye S.B., Anson C., and Powell A. Transit. Metal Chem. 28 (2003) 579
13. Schentag J.J. Clin. Ther. 22 (2000) 372
14. Woessner R.D., Mattern M.R., Mirabelli C.K., Jonson R.K., and Drako F.N. Cell Growth Differ. (1991) 209
15. Heck M.M., and Earnshaw W.C. J. Cell Biol. 103 (1986) 2569
16. Capranuco G., Tinelli S., Austin C.A., Fisher M.L., and Zunino F. Biochim. Biophys. Acta 1132 (1992) 43
17. Monnin K.A., Bronstein I.B., Gaffney D., and Holden J.A. Human Pathol. 30 (1999) 384
18. Koren R., Kugel V., Dekel Y., Weissman Y., Livne P.M., and Gal R. BJU Int. 91 (2003) 489
19. Järvinen T., and Liu E. Breast Cancer Res. Treat. 78 (2003) 299
20. Järvinen T., Kononen J., Pelto-Huikko M., and Isola J. Am. J. Pathol. 148 (1996) 2073
21. 1/2 vs. SCE = +0.44 V.
22. Macias B., Villa M., Rubio I., and Casterineras B.J. Inorg. Biochem. 84 (2001) 163
23. Drevensek P., Leban I., Turel T., Giester G., and Tillmans E. Acta Crystrallogr. C 59 (2003) m376
24. Turel I., and Golobic A. Anal. Sci. 19 (2003) 329
25. 1/2 vs. SCE = +0.32 V.
26. Ruiz M., Ortiz R., Perello L., Latorre J., and Server-Carrio J. J. Inorg. Biochem. 65 (1997) 87
27. Mendoza-Diaz G., Martinez-Aguilera L.M.R., Moreno-Esparza R., Pannell K., and Cervantes-Lee F. J. Inorg. Biochem. 50 (1993) 65
28. Wallis S., Gahan L., Charles B., Hambley T., and Duckworth P. J. Inorg. Biochem. 62 (1996) 1
29. Barve V., Ahmed F., Adsule S., Banarjee S., Kulkarni S., Katiyar P., Anson C., Powell A., Padhye S., and Sarkar F. J. Med. Chem. 49 (2006) 3800